Main Navigation

Quick Links

Startup news: The latest out of Salarius Pharmaceuticals, Sarcos and Techcyte

University of Utah startups continue innovating and discovering solutions to today’s unmet needs. Here’s a roundup of some of the latest news out of these companies:

Salarius Pharmaceuticals Reports No Adverse Safety Signals from Two Good Laboratory Practice Toxicology Studies with its Targeted Protein Degrader SP-3164

Salarius Logo

Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop cancer therapies for patients in need of new treatment options, announces the completion of two Good Laboratory Practice (GLP) toxicology studies with its targeted protein degrader SP-3164, with no unexpected safety findings during the course of either study. These GLP toxicology reports will be included in the Investigational New Drug (IND) application the company plans to submit to the U.S. Food and Drug Administration (FDA) in the second quarter of 2023.

Sarcos and VideoRay Sign Agreement to Offer Integrated Underwater Robotic Systems

Sarcos logo

Sarcos Technology and Robotics Corporation (“Sarcos”) (NASDAQ: STRC and STRCW), a leader in the design, development and manufacture of advanced robotic systems that redefine human possibilities, and VideoRay, the world’s leading manufacturer of underwater robotic systems, announced today that the companies have signed an agreement to offer integrated underwater robotic systems combining VideoRay remotely operated vehicles (ROVs) with the Sarcos Guardian® Sea Class robotic system including its power-efficient dexterous arms.

Zoetis Launches AI Dermatology for VETSCAN IMAGYST with Techcyte

Techcyte logo

In partnership with Zoetis, Techcyte has developed and launched AI-based dermatology algorithms and workflows for VETSCAN IMAGYST, the all-in-one deep learning SaaS platform. AI Dermatology joins AI-fecal analysis, AI-blood smear analysis, and remote cytology as the latest indication supported on the VETSCAN IMAGYST platform.

Oh, hello!

Contact Form